<DOC>
	<DOCNO>NCT00756184</DOCNO>
	<brief_summary>A one-year , randomize , attention placebo-controlled trial investigate value comprehensive adherence specific intervention , course one year , enhance adherence ( ) newly diagnose open-angle glaucoma , ocular hypertension patient , naive medical therapy ( b ) fail monotherapy prostaglandin analogue ( therefore candidate adjunctive therapy ) randomize receive travoprost monotherapy . Subjects randomize two different intervention involve direct physician education , take approximately amount physician time : The first intensive adherence education continue throughout year . The second intensive eye care education , without direct adherence education . All patient participate study monitor adherence TDA . The study demonstrate first time role adherence-specific training improve patient adherence validate TDA monitoring improve adherence glaucoma . This correlate prior work document great adherence associate marked improvement intraocular pressure ( IOP ) control . A second goal see whether improve adherence change course glaucoma therapy make therapeutic failure therapeutic success reduce need adjunctive therapy use monotherapy travoprost .</brief_summary>
	<brief_title>Value Intervention Enhance Adherence Glaucoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Newly diagnose patient glaucoma Suboptimally control patient glaucoma Untreated baseline IOP great 21 mm Hg le 32 mm Hg Patients respond satisfactorily PGA therapy Patients adjunctive therapy administer Patients consent participate trial Glaucoma patient high pressure Advanced glaucoma Patients side effect PGA therapy Unwilling participate</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Adherence</keyword>
	<keyword>Teaching</keyword>
</DOC>